AB0504 Efficacy of prolonged maintenance monotherapy with rituximab in patients with primary sjÖgren’s syndrome: three-year follow-up

Abstract

BackgroundThere are currently no effective systemic therapies of primary Sjögren’s syndrome (pSS); however, open label series have suggested that rituximab may be beneficial for systemic and glandular manifestations.ObjectivesTo estimate clinical...